...
首页> 外文期刊>BMC Anesthesiology >Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome
【24h】

Extra Corporeal Membrane Oxygenation (ECMO) in three HIV-positive patients with acute respiratory distress syndrome

机译:额外的急性呼吸窘迫综合征患者额外的额外的额外的物质膜氧合(ECMO)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Extracorporeal membrane oxygenation (ECMO) is a life-saving bridging procedure in patients with severe acute respiratory distress syndrome (ARDS). Official indications for ECMO are unclear for immunocompromised and HIV-positive patients affected by severe hypoxemia. Uncertainties are related to prognosis and efficacy of treatment of the underlying disease. However, the care of patients with HIV infection has advanced since the introduction of highly active antiretroviral therapy (HAART), with increased life expectancy and decreased mortality. Case presentation Three HIV-infected patients with AIDS were admitted to ICU and were treated with ECMO: a 21?years old Caucasian female with congenital HIV infection presented with Pneumocystis jirovecii pneumonia (PJP); a 38?years old Caucasian female with HIV-HCV infection and L. pneumophila pneumonia; a 24?years old Caucasian male with fever, cough weight loss and PJP pneumonia. Two patients were alive, with a good immunovirological profile and they went back to their previous quality of life. The last patient died with septic shock after three months of ICU stay. Conclusion ECMO was effective in three HIV-positive patients with an otherwise fatal respiratory failure. All patients had severe immunosuppression and/or limited antiretroviral options. A multidisciplinary critical team is needed to individualize the use of ECMO in immunocompromised patients, including those with HIV infection.
机译:背景技术体外膜氧合(ECMO)是严重急性呼吸窘迫综合征(ARDS)患者的节省救生桥接程序。对欧洲杂草的官方迹象尚不清楚受严重低氧血症影响的免疫功能性和艾滋病毒阳性患者。不确定性与治疗潜在疾病的预后和疗效有关。然而,由于引入高度活跃的抗逆转录病毒治疗(HAART)以来,艾滋病毒感染患者的护理提出,预期寿命增加并降低了死亡率。病例介绍艾滋病艾滋病患者患有ICU,并用Ecmo治疗:A 21?岁的白种人女性,具有先天性HIV感染的肺炎氏菌肺炎(PJP);一年38岁的白种人女性艾滋病毒HCV感染和L.Pneumophila肺炎;一个24岁的白种人男性发烧,咳嗽减肥和pjp肺炎。两名患者还活着,具有良好的免疫病学概况,他们回到了以前的生活质量。在ICU的三个月后,最后一次患者因脓毒症休克而死亡。结论ECMO在三个艾滋病毒阳性患者中有效,患有另一种致命的呼吸衰竭。所有患者均具有严重免疫抑制和/或有限的抗逆转录病毒选择。需要一个多学科关键队伍,以使ECMO在免疫功能性患者中使用ECMO,包括艾滋病毒感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号